AU2001236982A1 - A method of treating colon cancer by administering apigenin, luteolin, diosmetinand crysin - Google Patents

A method of treating colon cancer by administering apigenin, luteolin, diosmetinand crysin

Info

Publication number
AU2001236982A1
AU2001236982A1 AU2001236982A AU3698201A AU2001236982A1 AU 2001236982 A1 AU2001236982 A1 AU 2001236982A1 AU 2001236982 A AU2001236982 A AU 2001236982A AU 3698201 A AU3698201 A AU 3698201A AU 2001236982 A1 AU2001236982 A1 AU 2001236982A1
Authority
AU
Australia
Prior art keywords
diosmetinand
crysin
apigenin
luteolin
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001236982A
Inventor
Perry V Halushka
Thomas Walle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MUSC Foundation for Research Development
Original Assignee
MUSC Foundation for Research Development
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MUSC Foundation for Research Development filed Critical MUSC Foundation for Research Development
Publication of AU2001236982A1 publication Critical patent/AU2001236982A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AU2001236982A 2000-02-11 2001-02-12 A method of treating colon cancer by administering apigenin, luteolin, diosmetinand crysin Abandoned AU2001236982A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18207200P 2000-02-11 2000-02-11
US60182072 2000-02-11
US23277100P 2000-09-15 2000-09-15
US60232771 2000-09-15
PCT/US2001/004656 WO2001058410A2 (en) 2000-02-11 2001-02-12 A method of treating colon cancer by administering apigenin, luteolin, diosmetin and crysin

Publications (1)

Publication Number Publication Date
AU2001236982A1 true AU2001236982A1 (en) 2001-08-20

Family

ID=26877757

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001236982A Abandoned AU2001236982A1 (en) 2000-02-11 2001-02-12 A method of treating colon cancer by administering apigenin, luteolin, diosmetinand crysin

Country Status (2)

Country Link
AU (1) AU2001236982A1 (en)
WO (1) WO2001058410A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006105725A1 (en) * 2005-04-05 2006-10-12 Shanghai Gloriayx Biopharmaceuticals Co., Ltd A combination of luteolin and one of pt chemotherapeutics
GB201407694D0 (en) * 2014-05-01 2014-06-18 Univ Montfort Compound
CN104208598A (en) * 2014-09-26 2014-12-17 禤燕华 Chinese medicinal composition for treating chronic jaundice
CN106389405A (en) * 2015-07-30 2017-02-15 中国科学院大连化学物理研究所 A class of glucuronosyltransferase UGT1A1 inducers and applications thereof
CN114053414A (en) * 2021-12-31 2022-02-18 大连医科大学 Application of flavonoid compound USP22 inhibitor in preparation of anti-tumor immunity medicine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126129A (en) * 1988-05-23 1992-06-30 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Cancer therapy using interleukin-2 and flavone compounds
IN186803B (en) * 1997-02-05 2001-11-10 Panacea Biotec Ltd
GB9722600D0 (en) * 1997-10-24 1997-12-24 Bio Monde Holdings Internation Pharmaceutical compositon
US6087385A (en) * 1998-10-30 2000-07-11 University Of Mississippi Flavonoid derivatives

Also Published As

Publication number Publication date
WO2001058410A2 (en) 2001-08-16
WO2001058410A3 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
AU2001257342A1 (en) Treatment well tiltmeter system
AU2001260513A1 (en) Microcapsule well treatment
AU2002223827A1 (en) Well treatment
AU2002215125A1 (en) Well treatment method
AU2001282717A1 (en) Cancer treatment by combination therapy
AU2002339378A1 (en) Compartmentalized dosage form
AU2001251546A1 (en) Method for treating pain by peripheral administration of a neurotoxin
AU2001289309A1 (en) Improved safety syringe
AU2002250946A1 (en) Method for producing dentures
MXPA03000905A (en) Cyclic polyamine compounds for cancer therapy.
MXPA03003176A (en) Pyridinone derivatives for treatment of atherosclerosis.
AU2002303283A1 (en) Methods for treating drug addiction
AU2002363593A1 (en) Method for producing dentures
AU2001219185A1 (en) 2-acylaminobenzimidazole derivatives for treating glaucoma
MXPA03006268A (en) Therapeutic chromone compounds.
GC0000155A (en) 6-Hydroxy-indazole derivatives for treating glaucoma.
AU2000258650A1 (en) 2-piperidone compounds for the treatment of cancer
AU2000265525A1 (en) Medicament for treating intestinal diseases
AU2000272858A1 (en) Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments
AU751887B2 (en) Guide bar including stump treatment
AU9716001A (en) Guide bar including stump treatment
MXPA03007036A (en) Method of cancer therapy.
WO2001049654A3 (en) Substituted aminomethyl-phenyl-cyclohexane derivatives
AU2001236982A1 (en) A method of treating colon cancer by administering apigenin, luteolin, diosmetinand crysin
WO2001060343A3 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers